Bacopa vs Psychedelics: 5‑HT2A Boost Without Trips (Lucas Aoun)
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Bacopa vs Psychedelics: 5‑HT2A Boost Without Trips (Lucas Aoun)
-
Lu par :
-
De :
À propos de ce contenu audio
Join HOLOLIFE Academy: https://www.skool.com/hololife-academy/about
The video outlines the rapid growth of clinical research on classic psychedelics and explains that their shared mechanism is activation of the serotonin 5‑HT2A receptor. It then introduces Bacopa monnieri as a herbal source of ebolin lactone, a positive allosteric modulator of the same receptor, suggesting a way to obtain psychedelic-like cognitive benefits without hallucinations. The presenter stresses the need for standardized extracts and notes other compounds that can block the receptor.
- Clinical trials for classic psychedelics such as psilocybin, LSD, and MDMA have expanded dramatically, showing therapeutic potential for mental health conditions.
- All major psychedelics produce their effects by agonizing the serotonin 5‑HT2A receptor, a key driver of their subjective experiences.
- 5‑HT2A receptors are distributed throughout the body, influencing vascular, gastrointestinal, immune, and neural processes.
- Psychedelic-induced hallucinations stem from 5‑HT2A activation on cortical pyramidal neurons, disrupting thalamic filtering and increasing cortical excitability.
- Bacopa monnieri, a widely used Ayurvedic herb, contains the compound ebolin lactone, which interacts with the 5‑HT2A receptor.
- Ebolin lactone functions as a positive allosteric modulator of 5‑HT2A, enhancing serotonin’s natural activity without directly triggering a psychedelic trip.
- Standardized Bacopa extracts rich in ebolin lactone may replicate micro‑dosing benefits—enhanced cognition, creativity, and sensory processing—without hallucinogenic side effects.
- Only Bacopa products that are specifically standardized for ebolin lactone show this receptor‑modulating activity; generic supplements do not.
- Pharmaceuticals such as ciproheptadine, ketanserin, and olanzapine, as well as certain herbal extracts, can block 5‑HT2A and are used to counteract psychedelic effects.
- Pharma interest is growing in 5‑HT2A activation without hallucinations as a strategy for long‑lasting cognitive and mood improvements.
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment